Stay updated on Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Sign up to get notified when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.

Latest updates to the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page
- CheckyesterdayChange DetectedA new revision entry v3.5.3 has been added to the record history, and the previous v3.5.2 entry has been removed. This updates the page’s release notes in the history log.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision entry (v3.5.2) was added to the history. The previous revision entry (v3.5.0) was removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedThe record history now includes Revision v3.5.0 and omits Revision v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedThe record history now includes a new revision entry v3.4.3 and removes v3.4.2 from the history.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded Revision: v3.4.2 to the study history. Removed the government funding lapse notice and deleted Revision: v3.4.1.SummaryDifference0.8%

- Check86 days agoChange DetectedAdded a government funding notice and updated the page revision to v3.4.1, replacing the previous v3.4.0 in the history.SummaryDifference0.8%

Stay in the know with updates to Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crizotinib in ALK, MET, ROS1 Alterations Clinical Trial page.